UK to open stem cell center

Director Roger Pedersen expects to lure top US researchers for embryonic stem cell work

Written byPhilip Hunter
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The United Kingdom founded a new £16.5 million (USD $30 million) stem cell center in Cambridge this week with a commitment to fundamental research on both human embryonic and adult stem cells as a precursor to studying therapeutic applications.

The center's director, Roger Pedersen, professor of regenerative medicine at Cambridge University, dismissed calls to focus purely on adult and postnatal stem cells taken from the umbilical cord. "More than half of the research will be on embryonic stem cells," he told The Scientist. "We still don't understand 'stem-ness,' what it means to be able to differentiate to different cells, and we only know the identity of a handful of adult stem cells in the body, such as blood and muscle. However, embryonic stem cells by definition include all the other stem cells, so understanding them is a vital first step."

The United Kingdom has recently passed several milestones in stem ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies